Cipla
Lanreotide
Manufacturer:
Cipla
Name:
Lanreotide
HCPCS Code Descriptor:
Injection, lanreotide, (cipla), 1 mg
Category:
J Code
HCPCS:
J1932
NDC(s):
69097-0870-67
Primary Type:
Oncology
Generic/Specialty Status:
Single-Source
Route of Administration:
Subcutaneous
Potential NDC Listing Errors:
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
About:
Lanreotide is an Oncology drug manufactured by Cipla and administered via the Subcutaneous route of administration. The J Code: J1932 is aligned to the drug Lanreotide.